Compare GFL & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GFL | FMS |
|---|---|---|
| Founded | 2007 | 1996 |
| Country | Canada | Germany |
| Employees | N/A | N/A |
| Industry | | Misc Health and Biotechnology Services |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2B | 13.9B |
| IPO Year | 2020 | 1996 |
| Metric | GFL | FMS |
|---|---|---|
| Price | $44.49 | $22.00 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 11 | 2 |
| Target Price | ★ $56.50 | $30.00 |
| AVG Volume (30 Days) | ★ 1.7M | 599.4K |
| Earning Date | 02-11-2026 | 02-24-2026 |
| Dividend Yield | 0.14% | ★ 2.55% |
| EPS Growth | N/A | ★ 8.62 |
| EPS | ★ 6.65 | 2.86 |
| Revenue | $5,904,199,182.00 | ★ $23,046,819,198.00 |
| Revenue This Year | N/A | $2.13 |
| Revenue Next Year | $7.24 | $2.95 |
| P/E Ratio | ★ $6.72 | $14.61 |
| Revenue Growth | ★ 27.49 | 2.10 |
| 52 Week Low | $40.83 | $20.95 |
| 52 Week High | $52.00 | $30.46 |
| Indicator | GFL | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 58.51 | 42.32 |
| Support Level | $41.94 | $20.96 |
| Resistance Level | $42.91 | $22.50 |
| Average True Range (ATR) | 1.07 | 0.49 |
| MACD | 0.30 | -0.09 |
| Stochastic Oscillator | 78.61 | 34.12 |
GFL Environmental Inc is an environmental services company. Its offerings include non-hazardous solid waste management, infrastructure, soil remediation, and liquid waste management services. Its solid waste management business line, which generates the majority of the revenue, consists of the collection, transportation, transfer, recycling, and disposal of non-hazardous solid waste. Its Environmental Services business line includes liquid waste and soil remediation. The company's geographical segments are Canada and the United States. The company derives the majority of its revenue from the United States.
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.